Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke.

Lina GengKai PanYuhuan XuBizhu ZhangJing WangQian XueSanming ZhangHua SuBin Zhang

Published in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2024)

Co-positivity of aPLs and ANA/anti-ENA is an independent risk factor for RIS. However, HCQ therapy may reduce the recurrence rate of IS for these patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
systemic lupus erythematosus
peritoneal dialysis
atrial fibrillation
stem cells
patient reported outcomes
risk assessment